cbdMD, Inc.
YCBD
$0.86
-$0.05-5.50%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.22M | 19.48M | 20.64M | 21.58M | 23.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.22M | 19.48M | 20.64M | 21.58M | 23.45M |
| Cost of Revenue | 7.38M | 7.49M | 7.55M | 8.05M | 8.48M |
| Gross Profit | 11.84M | 12.00M | 13.09M | 13.53M | 14.97M |
| SG&A Expenses | 12.35M | 13.29M | 14.60M | 16.11M | 17.24M |
| Depreciation & Amortization | 1.16M | 1.15M | 1.53M | 1.62M | 1.71M |
| Other Operating Expenses | 627.90K | 835.70K | 2.81M | 3.08M | 3.09M |
| Total Operating Expenses | 21.56M | 22.80M | 26.52M | 28.91M | 30.62M |
| Operating Income | -2.34M | -3.32M | -5.88M | -7.32M | -7.17M |
| Income Before Tax | -2.69M | -3.70M | -19.42M | -21.65M | -19.98M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.69 | -3.70 | -19.42 | -21.65 | -19.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.69M | -3.70M | -19.42M | -21.65M | -19.98M |
| EBIT | -2.34M | -3.32M | -5.88M | -7.32M | -7.17M |
| EBITDA | -1.17M | -2.17M | -4.35M | -5.60M | -5.47M |
| EPS Basic | -15.18 | -18.84 | -151.56 | -159.67 | -162.73 |
| Normalized Basic EPS | -5.96 | -7.68 | -21.71 | -24.98 | -25.03 |
| EPS Diluted | -15.19 | -18.86 | -151.60 | -159.71 | -162.79 |
| Normalized Diluted EPS | -5.96 | -7.68 | -21.71 | -24.98 | -25.03 |
| Average Basic Shares Outstanding | 2.21M | 2.01M | 1.32M | 1.16M | 961.60K |
| Average Diluted Shares Outstanding | 2.21M | 2.01M | 1.32M | 1.16M | 961.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -3.43% | -7.70% | -13.35% |